{"id":"W4414320836","doi":"10.1182/bloodadvances.2025017611","title":"Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Sierra Oncology; Syndax Pharmaceuticals; Deutsche Krebshilfe; Pfizer; Edward P. Evans Foundation; Celgene; AstraZeneca; Swedish Orphan Biovitrum; Astex Pharmaceuticals","keywords":"Anemia; Adverse effect; Diarrhea; Myelodysplastic syndromes; Peripheral edema; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00566932,0.001826019,0.0133536,0.004434533,0.0004427196,0.002144013,0.001456061,0.001520726,0.004072504],"category_scores_gemma":[0.0112782,0.0009719595,0.02548486,0.005415598,0.000427259,0.001310866,0.0009241421,0.001454554,0.0003158127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001725664,"about_ca_system_score_gemma":0.002453317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004862803,"about_ca_topic_score_gemma":0.01192806,"domain_scores_codex":[0.9965565,0.001442968,0.001027715,0.0004100922,0.0004230885,0.0001396906],"domain_scores_gemma":[0.9941181,0.003736823,0.001284832,0.0001615192,0.0005878598,0.0001107849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002530038,0.00003446127,0.003226943,0.5408093,0.4363658,0.0001165261,0.00007402405,0.0004285955,0.000323677,0.0001196764,0.000935538,0.01503531],"study_design_scores_gemma":[0.0007378685,0.0002373973,0.004385533,0.03554179,0.956337,0.000113009,0.00004313624,0.0001891829,0.0001311932,0.0001526205,0.002107664,0.0000235543],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004203875,0.994416,0.0002476554,0.0001558839,0.00008160689,0.0001796216,0.0004652533,0.00001403426,0.0002361718],"genre_scores_gemma":[0.1500441,0.8457089,0.001160063,0.0008943341,0.0002279036,0.0006890632,0.0008729385,0.00002013712,0.0003824348],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0133536,"threshold_uncertainty_score":0.02998263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01488714063017105,"score_gpt":0.2902402542702914,"score_spread":0.2753531136401204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}